Related Experiment Video
Updated: Feb 23, 2026

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells
Yann Duchartre1, Yong-Mi Kim1, Michael Kahn2,3
1Division of Hematology and Oncology, Department of Pediatrics and Pathology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Abstract:
Wnt (Wingless-related integration site)-signaling orchestrates self-renewal programs in normal somatic stem cells as well as in cancer stem cells. Aberrant Wnt signaling is associated with a wide variety of malignancies and diseases. Although our understanding has increased tremendously over the past decade, therapeutic targeting of the dysregulated Wnt pathway remains a challenge. Here we review recent preclinical and clinical therapeutic approaches to target the Wnt pathway.
Insights
Wnt signaling controls cell renewal in stem cells and cancer. Targeting this pathway in diseases remains difficult, but new therapeutic strategies are emerging for Wnt pathway dysregulation.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Wnt signaling is crucial for self-renewal in normal somatic and cancer stem cells.
- Dysregulated Wnt signaling is implicated in numerous cancers and diseases.
- Despite advances, effectively targeting the Wnt pathway therapeutically is challenging.
Purpose of the Study:
- To review recent therapeutic strategies targeting the Wnt signaling pathway.
- To highlight preclinical and clinical approaches for Wnt pathway-associated diseases.
Main Methods:
- Literature review of preclinical studies.
- Analysis of clinical trial data.
- Synthesis of recent research on Wnt pathway therapeutics.
Main Results:
- Several therapeutic strategies targeting the Wnt pathway have shown promise in preclinical models.
- Early-phase clinical trials are investigating Wnt inhibitors for various malignancies.
- The review consolidates current knowledge on the therapeutic landscape of Wnt signaling.
Conclusions:
- Targeting Wnt signaling represents a promising therapeutic avenue for cancer and other diseases.
- Continued research and clinical investigation are essential to overcome challenges in Wnt pathway-targeted therapy.
- Developing effective Wnt inhibitors could significantly impact patient outcomes in Wnt-driven pathologies.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Targeted Cancer Therapies
There are several types of targeted therapies against...

